IT1320168B1 - Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide. - Google Patents

Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide.

Info

Publication number
IT1320168B1
IT1320168B1 IT2000TO000234A ITTO20000234A IT1320168B1 IT 1320168 B1 IT1320168 B1 IT 1320168B1 IT 2000TO000234 A IT2000TO000234 A IT 2000TO000234A IT TO20000234 A ITTO20000234 A IT TO20000234A IT 1320168 B1 IT1320168 B1 IT 1320168B1
Authority
IT
Italy
Prior art keywords
erythroid differentiation
induce
synthetic oligonucleotides
sequences corresponding
globin gene
Prior art date
Application number
IT2000TO000234A
Other languages
English (en)
Inventor
Nicoletta Bianchi
Giordana Feriotto
Roberto Gambari
Carlo Mischiati
Original Assignee
Univ Ferrara
Associazione Veneta Per La Lotta Alla Talassemia
Associazione Per La Lotta Alla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ferrara, Associazione Veneta Per La Lotta Alla Talassemia, Associazione Per La Lotta Alla filed Critical Univ Ferrara
Publication of ITTO20000234A0 publication Critical patent/ITTO20000234A0/it
Priority to IT2000TO000234A priority Critical patent/IT1320168B1/it
Priority to DE60117532T priority patent/DE60117532D1/de
Priority to PCT/EP2001/002804 priority patent/WO2001068147A2/en
Priority to EP01931516A priority patent/EP1263475B1/en
Priority to BR0109365-7A priority patent/BR0109365A/pt
Priority to AU2001258274A priority patent/AU2001258274A1/en
Priority to AT01931516T priority patent/ATE318617T1/de
Priority to US10/220,310 priority patent/US7262175B2/en
Publication of ITTO20000234A1 publication Critical patent/ITTO20000234A1/it
Application granted granted Critical
Publication of IT1320168B1 publication Critical patent/IT1320168B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT2000TO000234A 2000-03-13 2000-03-13 Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide. IT1320168B1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT2000TO000234A IT1320168B1 (it) 2000-03-13 2000-03-13 Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide.
BR0109365-7A BR0109365A (pt) 2000-03-13 2001-03-13 Oligonucleotìdeos sintéticos como indutores da diferenciação eritróide
PCT/EP2001/002804 WO2001068147A2 (en) 2000-03-13 2001-03-13 Synthetic oligonucleotides as inducers of erythroid differentiation
EP01931516A EP1263475B1 (en) 2000-03-13 2001-03-13 Synthetic oligonucleotides as inducers of erythroid differentiation
DE60117532T DE60117532D1 (de) 2000-03-13 2001-03-13 Synthetische oligonukleotide als erythroid differenzierungserreger
AU2001258274A AU2001258274A1 (en) 2000-03-13 2001-03-13 Synthetic oligonucleotides as inducers of erythroid differentiation
AT01931516T ATE318617T1 (de) 2000-03-13 2001-03-13 Synthetische oligonukleotide als erythroid differenzierungserreger
US10/220,310 US7262175B2 (en) 2000-03-13 2001-03-13 Synthetic oligonucleotides as inducers of erythroid differentiation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000TO000234A IT1320168B1 (it) 2000-03-13 2000-03-13 Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide.

Publications (3)

Publication Number Publication Date
ITTO20000234A0 ITTO20000234A0 (it) 2000-03-13
ITTO20000234A1 ITTO20000234A1 (it) 2001-09-13
IT1320168B1 true IT1320168B1 (it) 2003-11-18

Family

ID=11457577

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000TO000234A IT1320168B1 (it) 2000-03-13 2000-03-13 Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide.

Country Status (8)

Country Link
US (1) US7262175B2 (it)
EP (1) EP1263475B1 (it)
AT (1) ATE318617T1 (it)
AU (1) AU2001258274A1 (it)
BR (1) BR0109365A (it)
DE (1) DE60117532D1 (it)
IT (1) IT1320168B1 (it)
WO (1) WO2001068147A2 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20020582A1 (it) * 2002-07-04 2004-01-05 Univ Ferrara Nuovo uso della rapamicina e di suoi analoghi strutturali
DE102005061932A1 (de) 2005-12-23 2007-07-05 Biedermann Motech Gmbh Mehrwandiger Platzhalter
EP2424987B1 (en) * 2009-05-01 2017-11-15 CuRNA, Inc. Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
TW201839136A (zh) 2017-02-06 2018-11-01 瑞士商諾華公司 治療血色素異常症之組合物及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022738A (en) * 1995-03-03 2000-02-08 Mount Sinai School Of Medicine Of The City University Of New York Vectors for expression of globin genes
AU6328696A (en) * 1995-06-07 1996-12-30 Yale University Treatment of hemoglobinopathies
JPH11514864A (ja) * 1995-09-26 1999-12-21 ユニバーシティー オブ ワシントン ヘルペスウイルスのｒｆｈｖ／ｋｓｈｖ亜科の糖タンパク質ｂ
US5763488A (en) * 1995-10-30 1998-06-09 Vertex Pharmaceuticals Incorporated Methods and compositions using butyrate esters of threitol

Also Published As

Publication number Publication date
DE60117532D1 (de) 2006-04-27
WO2001068147A2 (en) 2001-09-20
ATE318617T1 (de) 2006-03-15
EP1263475A2 (en) 2002-12-11
US20030073660A1 (en) 2003-04-17
ITTO20000234A1 (it) 2001-09-13
ITTO20000234A0 (it) 2000-03-13
AU2001258274A1 (en) 2001-09-24
WO2001068147A3 (en) 2001-12-13
BR0109365A (pt) 2002-12-24
EP1263475B1 (en) 2006-03-01
US7262175B2 (en) 2007-08-28

Similar Documents

Publication Publication Date Title
DK3222722T3 (da) Antisense-design
MXPA04000179A (es) Oligonucleotidos sinteticos de hebra doble para inhibicion especifica de expresion de gene.
RS49990B (sr) Dnk sekvence vezane za kukuruzni transformant pv-zmgt 32 (nk 603) i preparati i metode za njegovu detekciju
DK0691980T3 (da) 7-deazapurinmodifiderende oligonukleotider
ATE460481T1 (de) Verfahren zur hemmung der expression eines zielgens und medikament zur therapie einer tumorerkrankung
AP2002002638A0 (en) Targeted chromosomal genomic alternations with modified single stranded oligonucleotides.
DK1013661T3 (da) 2'-O,4'-metylen bicyklonukleosid
GB2383330B (en) Expression system
WO2003040366A3 (fr) Oligonucleotides inhibiteurs et leur utilisation pour reprimer specifiquement un gene
ES2155959T3 (es) Oligonucleotidos cataliticos sinteticos.
IT1320168B1 (it) Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide.
ES2112062T3 (es) Oligonucleotidos con actividad anti-citomegalovirus.
IT1299184B1 (it) Sequenze nucleotidiche del gene lrpkm1 di melo, sequenze amminoacidiche e loro usi.
WO2001098522A3 (en) Positively-charged peptide nucleic acid analogs with improved properties
WO2003031459A3 (de) Modulation der expression stat-1-abhängiger gene
MXPA03009627A (es) MOLECULA SINTETICA DE ACIDO NUCLEICO PARA IMPARTIR CARACTERiSTICAS MULTIPLES.
MD2149F1 (en) Oligonucleotide primer for hepatitis C virus RNA detection
WO2001051670A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
DK1317548T3 (da) Transglutaminasegenprodukter
WO2003099990A3 (en) Compositions and methods for cloning nucleic acids
DK1537210T3 (da) Decoy-oligonukleotid-inhibering af CD40-ekspression
WO2002044382A8 (en) Cytokine-like proteins
ZA200102776B (en) Nucleotide sequences that code for the rpIK gene and methods of use thereof.
WO2002046380A3 (en) Protein kinase